Immunotherapy: The path to win the war on cancer?

Cell

Volumn 161, Issue 2, 2015, Pages 185-186

  Topalian, Suzanne L ^a   Wolchok, Jedd D ^b   Chan, Timothy A ^b   Mellman, Ira ^c   Palucka, Karolina ^d   Banchereau, Jacques ^d   Rosenberg, Steven A ^e   Wittrup, K Dane ^f  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c GENENTECH INC   (United States)

^d JACKSON LABORATORY   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 RECEPTOR;

ADOPTIVE TRANSFER; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; CELLULAR IMMUNITY; EPIGENETICS; GENE MUTATION; HUMAN; IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOREACTIVITY; IMMUNOSURVEILLANCE; MULTIPLE CANCER; MUTATION; NEOPLASM; PRIORITY JOURNAL; SHORT SURVEY; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; HISTORY; IMMUNOLOGY; IMMUNOTHERAPY; NEOPLASMS; TRENDS;

ADOPTIVE TRANSFER; CANCER VACCINES; HISTORY, 20TH CENTURY; HUMANS; IMMUNOTHERAPY; NEOPLASMS;

EID: 84927942436     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2015.03.045     Document Type: Short Survey

References (0)